Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI2350

Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.

R Niehues, M Hasilik, G Alton, C Körner, M Schiebe-Sukumar, H G Koch, K P Zimmer, R Wu, E Harms, K Reiter, K von Figura, H H Freeze, H K Harms, and T Marquardt

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Niehues, R. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Hasilik, M. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Alton, G. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Körner, C. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Schiebe-Sukumar, M. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Koch, H. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Zimmer, K. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Wu, R. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Harms, E. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Reiter, K. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by von Figura, K. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Freeze, H. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Harms, H. in: JCI | PubMed | Google Scholar

Klinik und Poliklinik für Kinderheilkunde, 48149 Münster, Germany.

Find articles by Marquardt, T. in: JCI | PubMed | Google Scholar

Published April 1, 1998 - More info

Published in Volume 101, Issue 7 on April 1, 1998
J Clin Invest. 1998;101(7):1414–1420. https://doi.org/10.1172/JCI2350.
© 1998 The American Society for Clinical Investigation
Published April 1, 1998 - Version history
View PDF
Abstract

Phosphomannose isomerase (PMI) deficiency is the cause of a new type of carbohydrate-deficient glycoprotein syndrome (CDGS). The disorder is caused by mutations in the PMI1 gene. The clinical phenotype is characterized by protein-losing enteropathy, while neurological manifestations prevailing in other types of CDGS are absent. Using standard diagnostic procedures, the disorder is indistinguishable from CDGS type Ia (phosphomannomutase deficiency). Daily oral mannose administration is a successful therapy for this new type of CDG syndrome classified as CDGS type Ib.

Version history
  • Version 1 (April 1, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts